Bloomberg TV: Sir Andrew Witty, CEO, GSK, discusses antibiotic resistance in Davos
- Related tags:
- Business Strategy
Andrew Witty, Chief Executive Officer, GSK, discusses antibiotic effectiveness, the issues surrounding drug pricing and corporate inversions. He speaks to Bloomberg's Jonathan Ferro and Hans Nichols on "Countdown" from the World Economic Forum in Davos, Switzerland, January 2016.
Explore more features